Work

Abstract B009: TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers

Year: 2023

Type: conference-abstract

Source: Molecular Cancer Research

DOI: 10.1158/1557-3125.ras23-b009

Authors: Alexander C. Edwards, Clint A. Stalnecker, Alexis J. Morales, Khalilah E. Taylor, Jill Hallin, Peter Olson, Tracy T. Tang, Lars Engstrom, Leonard Post, James G. Christensen, Adrienne D. Cox, Channing J. Der

Institutions: University of North Carolina at Chapel Hill, University of Pennsylvania, Mirati Therapeutics (United States)

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367603597

Cites:

Cited by: 1

Related to: 10